Pristimerin: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
{{Infobox | |||
{{Infobox drug | |||
| name = Pristimerin | | name = Pristimerin | ||
| image = | | image = <!-- Image file name --> | ||
| | | width = <!-- Image width --> | ||
| alt = <!-- Image alt text --> | |||
| | | caption = <!-- Image caption --> | ||
| cas_number = 1258-84-0 | |||
| | | pubchem = 73568 | ||
| | | chemspiderid = 66213 | ||
| chemical_formula = C<sub>30</sub>H<sub>40</sub>O<sub>4</sub> | |||
| molar_mass = 464.64 g/mol | | molar_mass = 464.64 g/mol | ||
}} | }} | ||
'''Pristimerin''' is a naturally occurring [[triterpenoid]] compound found in various plant species, particularly | '''Pristimerin''' is a naturally occurring [[triterpenoid]] compound found in various plant species, particularly in the [[Celastraceae]] family. It has been studied for its potential [[pharmacological]] properties, including [[anti-cancer]], [[anti-inflammatory]], and [[antioxidant]] effects. | ||
==Chemical Structure and Properties== | == Chemical Structure and Properties == | ||
Pristimerin is classified as a [[triterpenoid]], a | Pristimerin is classified as a [[quinonemethide triterpenoid]], characterized by its unique chemical structure that includes a [[quinone]] methide moiety. The [[molecular formula]] of Pristimerin is C<sub>30</sub>H<sub>40</sub>O<sub>4</sub>, and it has a [[molar mass]] of 464.64 g/mol. | ||
==Sources== | == Sources == | ||
Pristimerin is primarily | Pristimerin is primarily extracted from plants belonging to the Celastraceae family, such as ''[[Maytenus]]'' and ''[[Tripterygium]]'' species. These plants have been traditionally used in [[herbal medicine]] for their therapeutic properties. | ||
==Pharmacological Activities== | == Pharmacological Activities == | ||
Pristimerin has been the | === Anti-Cancer Activity === | ||
Pristimerin has shown promising [[anti-cancer]] activity in various [[in vitro]] and [[in vivo]] studies. It is believed to induce [[apoptosis]] in cancer cells by targeting multiple [[signaling pathways]], including the [[NF-κB]] and [[PI3K/Akt]] pathways. Pristimerin has been studied in the context of [[breast cancer]], [[prostate cancer]], and [[leukemia]]. | |||
===Anti- | === Anti-Inflammatory Effects === | ||
The compound exhibits significant [[anti-inflammatory]] effects by inhibiting the production of [[pro-inflammatory cytokines]] and mediators. It has been shown to suppress the activation of [[NF-κB]], a key transcription factor involved in the inflammatory response. | |||
=== | === Antioxidant Properties === | ||
Pristimerin also possesses [[antioxidant]] properties, which help in reducing [[oxidative stress]] by scavenging [[free radicals]]. This activity contributes to its potential therapeutic effects in preventing [[chronic diseases]] associated with oxidative damage. | |||
== | == Potential Applications == | ||
Pristimerin | Due to its diverse pharmacological activities, Pristimerin is being explored for potential applications in [[cancer therapy]], [[inflammatory diseases]], and as a [[neuroprotective]] agent. However, further research is needed to fully understand its mechanisms of action and to develop effective therapeutic formulations. | ||
== | == Safety and Toxicity == | ||
While Pristimerin has shown potential benefits, its [[safety profile]] and [[toxicity]] need to be thoroughly evaluated in [[clinical trials]]. Current studies suggest that it may have a narrow [[therapeutic window]], and its effects on [[human health]] require careful assessment. | |||
== | == See Also == | ||
* [[Triterpenoid]] | * [[Triterpenoid]] | ||
* [[Celastraceae]] | * [[Celastraceae]] | ||
* [[Apoptosis]] | * [[Apoptosis]] | ||
* [[NF-κB]] | * [[NF-κB]] | ||
== References == | |||
<references /> | |||
== External Links == | |||
* [PubChem Entry for Pristimerin](https://pubchem.ncbi.nlm.nih.gov/compound/Pristimerin) | |||
[[Category:Triterpenoids]] | [[Category:Triterpenoids]] | ||
[[Category: | [[Category:Pharmacology]] | ||
[[Category: | [[Category:Natural products]] | ||
[[Category:Anti- | [[Category:Anti-cancer agents]] | ||
Latest revision as of 20:45, 30 December 2024
| Pristimerin | |
|---|---|
| [[File:|frameless|220px|alt=|]] | |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Pristimerin is a naturally occurring triterpenoid compound found in various plant species, particularly in the Celastraceae family. It has been studied for its potential pharmacological properties, including anti-cancer, anti-inflammatory, and antioxidant effects.
Chemical Structure and Properties[edit]
Pristimerin is classified as a quinonemethide triterpenoid, characterized by its unique chemical structure that includes a quinone methide moiety. The molecular formula of Pristimerin is C30H40O4, and it has a molar mass of 464.64 g/mol.
Sources[edit]
Pristimerin is primarily extracted from plants belonging to the Celastraceae family, such as Maytenus and Tripterygium species. These plants have been traditionally used in herbal medicine for their therapeutic properties.
Pharmacological Activities[edit]
Anti-Cancer Activity[edit]
Pristimerin has shown promising anti-cancer activity in various in vitro and in vivo studies. It is believed to induce apoptosis in cancer cells by targeting multiple signaling pathways, including the NF-κB and PI3K/Akt pathways. Pristimerin has been studied in the context of breast cancer, prostate cancer, and leukemia.
Anti-Inflammatory Effects[edit]
The compound exhibits significant anti-inflammatory effects by inhibiting the production of pro-inflammatory cytokines and mediators. It has been shown to suppress the activation of NF-κB, a key transcription factor involved in the inflammatory response.
Antioxidant Properties[edit]
Pristimerin also possesses antioxidant properties, which help in reducing oxidative stress by scavenging free radicals. This activity contributes to its potential therapeutic effects in preventing chronic diseases associated with oxidative damage.
Potential Applications[edit]
Due to its diverse pharmacological activities, Pristimerin is being explored for potential applications in cancer therapy, inflammatory diseases, and as a neuroprotective agent. However, further research is needed to fully understand its mechanisms of action and to develop effective therapeutic formulations.
Safety and Toxicity[edit]
While Pristimerin has shown potential benefits, its safety profile and toxicity need to be thoroughly evaluated in clinical trials. Current studies suggest that it may have a narrow therapeutic window, and its effects on human health require careful assessment.
See Also[edit]
References[edit]
<references />
External Links[edit]
- [PubChem Entry for Pristimerin](https://pubchem.ncbi.nlm.nih.gov/compound/Pristimerin)
